文献速递前列腺增生与排尿功能障碍

良性前列腺增生微创治疗短期结果:经会阴激光消融与水蒸气消融首项随机试验

Short term results after minimally invasive treatments for benign prostatic enlargement: the first randomized trial comparing transperineal laser ablation and water vapor ablation.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2025-04-25

6个月时两组IPSS与QoL均较基线显著改善(p<0.001),TPLA在症状评分改善上更优且QoL改善更快;尿流参数两组均显著改善且无组间差异。两种门诊手术安全性相当。

要点

  • TPLA与WVA均能显著改善BPH患者IPSS、QoL及尿流参数,功能结局相当。
  • TPLA在6个月内症状评分改善优于WVA,QoL改善速度更快。
  • 两组均以门诊清醒镇静下完成,并发症少,仅1例前列腺脓肿为Clavien-Dindo≥3。

核心结论

  • TPLA与WVA均为安全的门诊微创手术,功能结局相当,但TPLA患者报告症状改善更快。

研究设计与样本

  • 两种手术均在清醒镇静下进行,患者同日出院,随访至术后3个月和6个月。

主要发现

  • 6个月时两组IPSS和QoL均较基线显著改善(p<0.001),TPLA在3个月和6个月两个时间点均更优(p≤0.03)。
  • 一般线性模型分析显示TPLA组QoL改善更快(p=0.005),但6个月时组间差异不再显著。
  • 最大尿流率、平均尿流率和残余尿量两组均显著改善(所有比较p<0.001),组间无显著差异。
  • 术后并发症共11例,仅1例(前列腺脓肿)为Clavien-Dindo≥3;除1例需延长持续膀胱冲洗外,所有患者均同日出院。

临床怎么用

  • 对于寻求门诊微创治疗的BPH患者,TPLA和WVA均可作为安全选择,功能结局相当。
  • 若优先考虑患者报告症状的快速改善,TPLA可能更具优势。

局限性

  • 样本量有限。
  • 随访时间短(仅6个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interest in minimally invasive techniques (MISTs) for treating benign prostatic hyperplasia (BPH) has increased over the years due to their ability to improve symptoms while minimizing complications. Moreover, these procedures can be performed in an outpatient setting, potentially reducing patients' discomfort. The aim of our randomized trial is to evaluate and compare the efficacy of Transperineal Laser Ablation (TPLATM) and Water Vapor Ablation (WVA) in the treatment of BPH. METHODS: Eighty consecutive patients were randomized 1:1 to the two techniques between January and July 2024. Both procedures were under conscious sedations and patients were same day discharged. All patients underwent standardized follow-up, including International Prostate Symptoms Score (IPSS) and uroflowmetry assessments at 3- and 6-months post-treatment. RESULTS: At 6 months, IPSS and Quality of Life (QoL) scores improved significantly from baseline (p < 0.001), in favor of TPLA at both time points (p ≤ 0.03). General Linear Model analysis showed that QoL improvement was faster in the TPLA group (p: 0.005), though no significant difference persisted at 6 months. Uroflow parameters, including maximum flow, average flow, and post-void residual volume, demonstrated significant improvement without notable differences between the two groups (p < 0.001 for all comparisons). All patients were same day discharged, except one who required prolonged continuous bladder irrigation. Postoperative complications occurred in 11 cases, with only one (a prostatic abscess) classified as Clavien-Dindo ≥3. The main limitations of the study are the sample size and short follow-up duration. CONCLUSIONS: TPLA and WVA are safe outpatient procedures that provide comparable functional outcomes. However, TPLA appears to offer a faster improvement in patient-reported symptoms.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Pacini M, Zucchi A, Salonia A, et al. Short term results after minimally invasive treatments for benign prostatic enlargement: the first randomized trial comparing transperineal laser ablation and water vapor ablation. Prostate Cancer Prostatic Dis. 2025. PMID: 40281201. doi:10.1038/s41391-025-00972-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。